NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia

RecruitingPhase 4

Sponsor: Mahidol University

Conditions: Bacteremia, Streptococcus Infection

Interventions: Beta-lactam monotherapy, Beta-lactam plus levofloxacin combination therapy

Countries: Thailand

A double-blind randomized controlled trial comparing beta-lactam plus levofloxacin versus beta-lactam monotherapy for the treatment of Streptococcal bacteremia

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

1. Adults age\>18 years
2. Blood culture positive for Streptococcus (\<72 hours before enrollment)

   * at least 1 bottle of S. pyogenes, S. agalactiae, S. pneumoniae, S. suis
   * at least 2 bottle of other Streptococci
3. Receiving or having plan of receiving beta-lactam therapy

Exclusion Criteria:

1. Known allergy to beta-lactam or fluroquinolone antibiotics
2. Pregnancy or lactating mother
3. EKG with QT prolongation
4. Diagnosis of infective endocarditis

Locations (4)

Bangkok, Thailand
Chiang Mai, Thailand
Nakhon Ratchasima, Thailand
Ratchaburi, Thailand